Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii

Keigo Ueno1, Yuki Kinjo2, Yoichiro Okubo3

  • 1Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan.

Infection and Immunity
|February 4, 2015
PubMed
Summary

A novel dendritic cell (DC) vaccine using an acapsular Cryptococcus gattii strain protected mice against infection. This approach boosted immune responses, including gamma interferon (IFN-γ), and improved survival rates.

Related Concept Videos